Published in J Exp Med on January 04, 1999
Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J Exp Med (2000) 1.63
Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J Exp Med (2006) 1.59
Intracellular survival of Leishmania major in neutrophil granulocytes after uptake in the absence of heat-labile serum factors. Infect Immun (2002) 1.39
Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes. Blood (2011) 1.02
Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study. BMC Infect Dis (2004) 0.91
Complement interaction with trypanosomatid promastigotes in normal human serum. J Exp Med (2002) 0.90
Polarized expression of Tamm-Horsfall protein by renal tubular epithelial cells activates human granulocytes. Infect Immun (2002) 0.89
Complement receptor 3 deficiency influences lesion progression during Leishmania major infection in BALB/c mice. Infect Immun (2009) 0.85
Transcriptional inhibition of interleukin-12 promoter activity in Leishmania spp.-infected macrophages. J Parasitol (2008) 0.85
Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies. Immunology (2006) 0.83
Dendritic cells in Leishmania major infections: mechanisms of parasite uptake, cell activation and evidence for physiological relevance. Med Microbiol Immunol (2012) 0.82
Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription. Parasite Immunol (2013) 0.82
Kinetic analysis of ex vivo human blood infection by Leishmania. PLoS Negl Trop Dis (2010) 0.81
The roles of complement receptor 3 and Fcγ receptors during Leishmania phagosome maturation. J Leukoc Biol (2013) 0.79
Distinct cellular migration induced by Leishmania infantum chagasi and saliva from Lutzomyia longipalpis in a hemorrhagic pool model. Rev Inst Med Trop Sao Paulo (2014) 0.75
Red blood cell complement receptor one level varies with Knops blood group, α(+)thalassaemia and age among Kenyan children. Genes Immun (2016) 0.75
Differential surface deposition of complement proteins on logarithmic and stationary phase Leishmania chagasi promastigotes. J Parasitol (2012) 0.75
Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development. Front Immunol (2017) 0.75
The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters. Biochem J (1974) 14.12
C3 shunt activation in human serum chelated with EGTA. J Immunol (1972) 6.94
P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature (1997) 4.84
The kinetics of antibody binding to membrane antigens in solution and at the cell surface. Biochem J (1980) 4.37
Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J Exp Med (1983) 3.96
Immune adherence by the fourth component of complement. Science (1969) 3.34
Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J Immunol (1985) 3.02
Blood-feeding arthropods: live syringes or invertebrate pharmacologists? Infect Agents Dis (1995) 2.81
The role of antibody concentration and avidity in antiviral protection. Science (1997) 2.45
Mechanism of lethal effect of human serum upon Leishmania donovani. J Immunol (1980) 2.08
Nonopsonic phagocytosis of microorganisms. Annu Rev Microbiol (1995) 1.82
Leishmania donovani: promastigote--macrophage surface interactions in vitro. Exp Parasitol (1979) 1.79
The third component of complement (C3) is responsible for the intracellular survival of Leishmania major. Nature (1987) 1.78
Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J Immunol (1995) 1.77
CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J Immunol (1989) 1.72
Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages. J Immunol (1984) 1.66
Phagocytosis and killing of the protozoan Leishmania donovani by human polymorphonuclear leukocytes. J Immunol (1981) 1.65
Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J Exp Med (1988) 1.51
Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor. Immunology (1983) 1.35
Early histopathology of experimental infection with Leishmania donovani in hamsters. J Parasitol (1987) 1.32
Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. J Leukoc Biol (1992) 1.31
Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells. Clin Exp Immunol (1982) 1.26
Increased myelopoiesis during Leishmania major infection in mice: generation of 'safe targets', a possible way to evade the effector immune mechanism. Clin Exp Immunol (1986) 1.25
Leishmanicidal mechanisms of human polymorphonuclear phagocytes. Am J Trop Med Hyg (1981) 1.20
Immunogenic Gal alpha 1----3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania. J Immunol (1989) 1.13
Mapping epitopes for 20 monoclonal antibodies to CR1. Clin Exp Immunol (1998) 1.12
The biochemistry of opsonization: central role of the reactive thiolester of the third component of complement. J Infect Dis (1984) 1.11
Interaction of Leishmania donovani promastigotes with human monocyte-derived macrophages: parasite entry, intracellular survival, and multiplication. Infect Immun (1981) 1.10
Cooperation between CR1 (CD35) and CR3 (CD 11b/CD18) in the binding of complement-opsonized particles. J Leukoc Biol (1996) 1.09
Interferon-gamma-dependent modulation of C3b receptors (CR1) on human peripheral blood monocytes. J Immunol (1986) 1.08
Binding and release of C3 from Leishmania donovani promastigotes during incubation in normal human serum. J Immunol (1989) 1.08
Leishmania species: mechanisms of complement activation by five strains of promastigotes. Exp Parasitol (1986) 1.07
Leishmania-macrophage interactions: multiple receptors, multiple ligands and diverse cellular responses. Semin Cell Biol (1993) 1.04
Leishmania major-human macrophage interactions: cooperation between Mac-1 (CD11b/CD18) and complement receptor type 1 (CD35) in promastigote adhesion. Infect Immun (1996) 1.03
Attachment of plasma membrane vesicles of human macrophages to Leishmania tropica promastigotes. J Infect Dis (1983) 1.03
Infection of tissue culture cells of low phagocytic ability by Leishmania mexicana mexicana. Ann Trop Med Parasitol (1974) 1.00
Characteristics of so-called natural antibodies in various normal sera against culture forms of Leishmania. J Parasitol (1970) 0.97
Natural autoantibodies: the other side of the immune system. Res Immunol (1996) 0.95
Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells. J Immunol (1987) 0.95
Mouse monoclonal antibodies to the human C3b receptor. Mol Immunol (1985) 0.94
Granulocytes in the inflammatory process of BALB/c mice infected by Leishmania amazonensis. A quantitative approach. Acta Trop (1991) 0.92
Pathophysiology of experimental leishmaniasis: pattern of development of metastatic disease in the susceptible host. Infect Immun (1986) 0.92
Exploitation of the complement system by Leishmania promastigotes. Parasitol Today (1996) 0.91
Effect of immunoglobulin M from normal human serum on Leishmania donovani promastigote agglutination, complement-mediated killing, and phagocytosis by human monocytes. Infect Immun (1989) 0.89
The interaction of Leishmania donovani promastigotes and human fibroblasts in vitro. Am J Trop Med Hyg (1985) 0.88
Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells. J Immunol (1989) 0.88
The effect of fresh serum on the leptomonads of Leishmania. I. Preliminary report. Trans R Soc Trop Med Hyg (1968) 0.88
Cutaneous host defense in leishmaniasis: interaction of isolated dermal macrophages and epidermal Langerhans cells with the insect-stage promastigote. Infect Immun (1988) 0.88
Invasion of murine dendritic cells by Leishmania major and L. mexicana mexicana. J Parasitol (1988) 0.84
Macrophage-parasite interaction in the lesions of cutaneous leishmaniasis. An ultrastructural study. Am J Pathol (1986) 0.81
Antigen presentation by epidermal Langerhans cells in experimental cutaneous leishmaniasis. Parasite Immunol (1994) 0.76
Human erythrocytes inhibit complement-mediated solubilization of immune complexes. J Immunol (1989) 0.76
Location and structural significance of the oligosaccharides in human Ig-A1 and IgA2 immunoglobulins. Proc Natl Acad Sci U S A (1977) 1.36
Complete amino acid sequence of the alpha 2 heavy chain of a human IgA2 immunoglobulin of the A2m (2) allotype. Proc Natl Acad Sci U S A (1978) 1.35
Ontogenic restriction of colonization of the bursa of Fabricius. Eur J Immunol (1983) 0.88
Soluble protein factors and ribosomal subunits from yeast. Interactions with aminoacyl-tRNA. Methods Enzymol (1974) 0.88
Leishmania immune adherence reaction in vertebrates. Parasite Immunol (2001) 0.86
Periodate oxidation of R36A pneumococci greatly enhances production of hybridomas secreting anti-protein antibodies. Microb Pathog (1998) 0.81
Bile acid secretion during rat liver carcinogenesis. Life Sci (2000) 0.76
Polymerization factors in yeast. Basic Life Sci (1973) 0.75